#36: Value Pricing Bootcamp: A Crash Course in How to Use Real World Evidence to Better Measure Outcomes and Evaluate New Innovative Therapies
Duane Schulthess, MBA
- Managing Director
- Vital Transformation, Belgium
Duane is the Managing Director of Vital Transformation which consults to national health authorities, blue chip multi-national organisations, governments, and stakeholder groups on healthcare policy and technology. He and his firm have developed many unique techniques and methods to harness Real World Evidence to evaluate new therapies, which are often discussed on their widely followed weekly Vital Health Podcast Series. Duane was formerly the EMEA Head of Corporate Development of The Wall Street Journal.
Luca Pani, MD
- Former, AIFA; Professor, Department of Psychiatry and Behavioral Sciences
- University of Miami, United States
Luca Pani is Professor of Clinical Psychiatry, Department of Psychiatry and Behavioral Sciences, University of Miami, and Executive Director for Global Medical Innovation, NeuroCog Trials, USA. As former Director General of the Italian Medicines Agency (AIFA) and member of the CHMP and SAWP for EMA in London, he is a recognized expert in psychopharmacology, clinical psychiatry and regulatory science with particular emphasis on health technology assessment linked with novel negotiation strategy.
- Pharmacoeconomics Advisor
- Zorginstituut Nederland, Belgium
Amr is a pharmacist by training, having completed his PharmD degree in Egypt before moving to the Netherlands to pursue his Master’s studies at Utrecht University in the field of pharmaceutical policy. Recently, Amr completed his PhD degree at Utrecht University whereby his thesis focused on the use of Real-World Evidence (RWE) in HTA practice. Currently, Amr works as a pharmacoeconomic assessor and policy advisor at the Dutch National Health Care Institute (ZIN) within the team of internal medicine. Moreover, he is involved in a number of international projects related to RWE generation and use in decision-making, including: IMI-GetReal I/II, IMI-ROADMAP, EUnetHTA JA3 and NEWDIGS.
- Clinical Scientist
- Nashville Biosciences, United States
Dr. Raffoul is an Internal Medicine trained M.D./Ph.D. from Wayne State University who has studied the molecular effects of DNA repair deficiencies on aging and cancer phenotypes, completing a fellowship in molecular therapeutics at the Karmanos Cancer Institute. He also completed an M.B.A. from Auburn University and joined Nashville Biosciences and Vanderbilt University Medical Center as a clinical scientist to lead the clinical design of precision medicine studies.
- Senior Director, Office of the Chief Hospital Information Officer
- Vanderbilt University Medical Center, United States
Brian Rothman, MD, is Associate Professor of Anesthesiology and Medical Director of Perioperative Informatics at Vanderbilt University Medical Center. He received his medical degree from the University of Cincinnati and completed his residency at The Johns Hopkins Hospital. He is President-Elect for the Society for Technology in Anesthesia (STA) and serves several other societies. He works to enhance Vanderbilt's EHR, VPIMS, improving perioperative efficiency, communication, and patient safety.